CLINICAL_TRIALS
trial_result
· 2024-08-23
Clinical Trial Update: A Study of IBI362 in Participants With Type 2 Diabetes [Phase 3]
Summary
This updates on a Phase 3 study of IBI362 in participants with Type 2 diabetes. The trial status is completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Innovent Biologics (Suzhou) Co. Ltd. | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED